Articles

Calliditas Articles

October 19, 2020Micro Small CapNews

Calliditas Announces Poster and Presentation at ASN Digital Kidney Week 2020

Calliditas Announces Poster and Presentation at ASN Digital Kidney Week 2020PR NewswireSTOCKHOLM, Oct... See more »
October 18, 2020RTTNewsNews

On The Watch For Nefigard Data

Shares of Calliditas Therapeutics AB (CALT) have gained nearly 21% so far this month, as the company ... See more »
October 1, 2020CisionPress Release

The 200[th] patient's last visit completed in Part A of NefIgArd supporting topline readout in pivotal Phase 3 trial in Q4, 2020

Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the last visit of the 200th... See more »
September 30, 2020Micro Small CapNews

Number of shares and votes in Calliditas Therapeutics

Calliditas-TherapeutiNumber of shares and votes in Calliditas TherapeuticsPR NewswireSTOCKHOLM, Sept.... See more »
September 8, 2020Micro Small CapNews

First patient in China enrolled in clinical phase 3 study NefIgArd with lead candidate Nefecon

STOCKHOLM, Sept. 8, 2020 /PRNewswire/ - Calliditas Therapeutics AB (publ) ("Calliditas") today announ... See more »
August 25, 2020FinanzNachrichtenNews

Calliditas appoints Group General Counsel

STOCKHOLM , Aug. 25, 2020 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today anno... See more »
August 13, 2020BioSpaceNews

Interim Report Q2, 2020

"In June we successfully closed a $90m U.S. IPO on NASDAQ, which including the greenshoe that was exe... See more »
July 2, 2020BioSpaceNews

Exercise of Over-allotment Option and End of the Stabilization Period - July 02, 2020

Citigroup Global Markets Inc., in its capacity as Joint Global Coordinator, notifies that the stabili... See more »
June 30, 2020FinanzNachrichtenNews

Number of Shares and Votes in Calliditas Therapeutics

STOCKHOLM, June 30, 2020 /PRNewswire/ -- During June, Calliditas Therapeutics AB (publ) has issued 9,... See more »
June 22, 2020CisionPress Release

CEO Rene Aguiar-Lucander exercises warrants and invests SEK 15.7m (appr. USD 1.7m) in Calliditas

Calliditas Therapeutics AB (publ) ("Calliditas") today announced that its CEO Renée Aguiar-Lucander... See more »
May 14, 2020centralchartsPress Release

Calliditas Publicly Files Registration Statement With SEC for a Proposed Initial Public Offering in the United States

Calliditas Publicly Files Registration Statement With SEC for a Proposed Initial Public Offering in t... See more »
April 27, 2020StreetInsiderPress Release

Calliditas Provides a Corporate Business Update in the Context of the COVID-19 Pandemic

STOCKHOLM, Sweden, April 27, 2020 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") to... See more »
March 30, 2020PR NewswirePress Release

Calliditas Moves its Annual General Meeting 2020 to June 25

/PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced that due to the rece... See more »
March 3, 2020PR NewswirePress Release

Bulletin From the Extraordinary General Meeting of Calliditas Therapeutics AB (publ)

STOCKHOLM, March 3, 2020 /PRNewswire/ -- As part of the preparations for a potential offering of Amer... See more »
November 14, 2019centralchartsPress Release

Interim Report Q3, 2019

Interim Report Q3, 2019 Positive Regulatory Outcome - Enhanced study design PR Newswire STOCKHOLM, No... See more »
November 4, 2019StreetInsiderPress Release

Calliditas Therapeutics Capital Markets Day Today November 4

STOCKHOLM, Nov. 4, 2019 /PRNewswire/ -- Calliditas Therapeutics ("Calliditas") today hosts a Capital ... See more »
October 1, 2019StreetInsiderPress Release

Positive Interactions With EMA Provide Route to Conditional Marketing Authorization of Lead Candidate Nefecon

STOCKHOLM, Oct. 1, 2019 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announ... See more »
Loading interface...
Loading interface...
Loading interface...
Loading interface...